Nori A, Furlan S, Patiri F, Cantini M, Volpe P
Centro di Studio per la Biologia e la Fisiopatologia Muscolare del CNR, Dipartimento di Scienze Biomediche Sperimentali, Università di Padova, viale G. Colombo 3, Padova, 35121, Italy.
Exp Cell Res. 2000 Oct 10;260(1):40-9. doi: 10.1006/excr.2000.4989.
Calsequestrin (CS) is segregated to the junctional sarcoplasmic reticulum (jSR) of skeletal muscle fibers and is responsible for intraluminal Ca(2+) binding. A chimeric CS-HA1, obtained by adding the nine-amino-acid viral epitope hemagglutinin (HA1) to the carboxy-terminal of CS and shown to be correctly segregated to skeletal muscle jSR in vivo (A. Nori, K. A. Nadalini, A. Martini, R. Rizzuto, A. Villa, and P. Volpe, 1997, Am. J. Physiol. 272, C1420-C1428), is mutagenized in order to identify domains of CS involved in targeting. Since a putative targeting mechanism of CS implies phosphorylation-dependent steps in the endoplasmic reticulum (ER) and/or Golgi complex, five CS-HA1 mutants disrupting the three phosphorylation sites of CS (Thr(189), Thr(229), and Thr(353)) were engineered by either site-directed mutagenesis or deletion: CS-HA1DeltaP1 (Thr(189) --> Ile); CS-HA1DeltaP2 (Thr(229) --> Asn); CS-HA1DeltaP1,2; in which Thr(189) and Thr(229) were changed to Ile and Asn, respectively; and CS-HA1Delta14(COOH) and CS-HA1Delta49 (COOH), in which 14 residues (Glu(354)-Asp(367)) and 49 residues (Asp(319)-Asp(367)), respectively, were deleted at the carboxy-terminal. Mutant cDNAs were transiently transfected in either HeLa cells, cultured myoblasts of rat skeletal muscle, or regenerating soleus muscle fibers of adult rats. Each CS-HA1 mutant was identified by Western blot as a single polypeptide of the predicted molecular weight. The intracellular localization of CS-HA1 mutants was studied by immunofluorescence using specific antibodies against either CS or HA1. CS-HA1 mutants colocalized with ER markers, e.g., calreticulin, and partially overlapped with Golgi complex markers, e.g., alpha-mannosidase II, in HeLa cells and myotubes. CS-HA1 mutants were expressed and retained in ER and ER/SR of HeLa cells and myotubes, respectively, and correctly segregated to jSR of regenerating soleus muscle fibers. Thus, the targeting mechanism of CS in vivo is not affected by phosphorylation(s); i.e., sorting and segregation of CS appear to be independent of posttranslational phosphorylation(s).
肌集钙蛋白(CS)定位于骨骼肌纤维的连接肌质网(jSR),负责腔内Ca(2+)的结合。通过在CS的羧基末端添加九个氨基酸的病毒表位血凝素(HA1)获得的嵌合CS-HA1,已证实在体内能正确定位于骨骼肌jSR(A. Nori、K. A. Nadalini、A. Martini、R. Rizzuto、A. Villa和P. Volpe,1997,《美国生理学杂志》272卷,C1420 - C1428页),为了确定CS中参与靶向定位的结构域,对其进行了诱变。由于CS推测的靶向机制涉及内质网(ER)和/或高尔基体复合体中依赖磷酸化的步骤,通过定点诱变或缺失构建了五个破坏CS三个磷酸化位点(Thr(189)、Thr(229)和Thr(353))的CS-HA1突变体:CS-HA1DeltaP1(Thr(189)→Ile);CS-HA1DeltaP2(Thr(229)→Asn);CS-HA1DeltaP1,2,其中Thr(189)和Thr(229)分别变为Ile和Asn;以及CS-HA1Delta14(COOH)和CS-HA1Delta49(COOH),其中分别在羧基末端缺失了14个残基(Glu(354)-Asp(367))和49个残基(Asp(319)-Asp(367))。将突变体cDNA瞬时转染入HeLa细胞、大鼠骨骼肌培养的成肌细胞或成年大鼠再生的比目鱼肌纤维中。通过蛋白质免疫印迹法将每个CS-HA1突变体鉴定为预测分子量的单一多肽。使用针对CS或HA1的特异性抗体,通过免疫荧光研究CS-HA1突变体的细胞内定位。在HeLa细胞和肌管中,CS-HA1突变体与ER标记物(如钙网蛋白)共定位,并与高尔基体复合体标记物(如α-甘露糖苷酶II)部分重叠。CS-HA1突变体分别在HeLa细胞和肌管的ER和ER/SR中表达并保留,且正确定位于再生比目鱼肌纤维的jSR中。因此,CS在体内的靶向机制不受磷酸化的影响;即,CS的分选和定位似乎独立于翻译后磷酸化。